Ovarian cancer has long proved difficult to treat. Could the answer lie within the disease itself? Discover how synthetic ...

Sanjeev Luther is President and CEO of Ernexa Therapeutics and a member of the Board of Directors. Sanjeev is a seasoned ...

Stanford University researchers have demonstrated that stem cell-derived vascular organoids can regenerate damaged ...

Preclinical findings from Genespire and SR-TIGET suggest a single administration of a liver-directed lentiviral gene therapy ...

A repurposed small molecule originally developed for spinal cord injury has demonstrated the ability to address multiple ...

A newly identified experimental compound, XL20, has demonstrated neuroprotective effects in mouse models and human motor ...

Researchers have identified 15-PGDH enzyme inhibition as a neuroprotective strategy in Parkinson's disease, with repurposable ...

A collaborative research team from LJI, Scripps Research and IAVI has developed an experimental HIV vaccine that successfully ...

Researchers at UMass Amherst have combined high-throughput laboratory screening with an AI neural network to identify ...

Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...

A commonly prescribed epilepsy drug has shown striking potential as a vaccine booster in a controlled human trial, more than ...

One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the ...